The companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.

Gilead and Merck & Co. have guided their once-weekly HIV combination therapy past another milestone, linking the cocktail to ...

Sweden has surpassed the UNAIDS 95-95-95 targets, with reduced HIV incidence and a steady increase in diagnosed and treated ...

HIV-infection leads to severe depletion of CD4+ T-cells, increasing susceptibility to opportunistic infections and cancers, ultimately leading to death in the absence of treatment. Antiretroviral ...

In this cross-sectional study, researchers explored immune activation as a possible mechanism for this seemingly paradoxical response to HIV infection. CD4-cell counts and T-cell activation levels ...

The symptoms only last for a few weeks, and then you usually don’t have symptoms again for years. But HIV can be spread to other people — whether or not you have symptoms or feel sick. HIV destroys ...

Those include Sunlenca, which is approved for resistant HIV as a twice-yearly injection after an initial oral regimen, and ...

And people with HIV do not always have AIDS. HIV is the virus that’s passed from person to person. Over time, HIV destroys an important kind of the cell in your immune system (called CD4 cells or T ...

This study investigated the impact of fentanyl on HIV replication in CD4 + T lymphocytes. Results: Results indicated that fentanyl treatment increased HIV p24 expression and proviral DNA levels, and ...

The Department of Health (DOH) on Friday urged the public to get tested early for human immunodeficiency virus-acquired ...